NEW! Lymphedema After Breast Cancer Sat, Sep 29 4:30-6:00 p.m.

Lymphedema is a debilitating condition that is crippling for many patients and predominantly results from treatment for cancer in the modern industrialized world. Patients undergoing treatment for breast cancer who have undergone an axillary lymph node dissection (ALND), radiation therapy, and chemotherapy are at exceedingly high risk for developing lymphedema. Prior treatment strategies have focused on debulking the arm with direct excision or liposuction; however, two novel techniques have evolved that provide a more physiologic solution to treating breast cancer related lymphedema.

Supermicrosurgical treatment of lymphedema has proven to be remarkably effective in improving patients’ quality of life following treatment for breast cancer. As the field continues to develop, new techniques and novel advances are continually emerging to maximize outcomes while minimizing complications. Both the lymphaticovenular anastomosis (LVA) technique and vascularized lymph node transfer (VLNT) approach will be discussed specifically for the treatment of post mastectomy lymphedema syndrome.

The program aims to provide an evidence-based approach to the diagnosis, staging, and treatment of lymphedema as well as provide an algorithm and approach from an expert panel who have performed high volume lymphatic surgery with reliable, reproducible results. In particular the panel will focus on pearls and pitfalls for performing and establishing a lymphedema practice and will also discuss issues with coding and reimbursement.

At the end of this activity, participants will be able to:

  1. Discuss the surgical options available for treating breast cancer related lymphedema
  2. Recognize potential risks and post operative complications with the surgical options
  3. Identify the appropriate patient who is a candidate for surgical treatment
  4. Define an approach and algorithm to provide the optimal outcome in patients with breast cancer lymphedema
  5. Discuss the staging and classification of lymphedema which dictates the treatment modality

Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.

Designation: The ASPS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.